My NCBISign In

Display Settings:

Format
Items per page
Sort by

Send to:

Choose Destination

    Results: 1 to 20 of 130

    1.

    Cerebrospinal fluid markers in Creutzfeldt-Jakob disease.

    Skinningsrud A, Stenset V, Gundersen AS, Fladby T.

    Cerebrospinal Fluid Res. 2008 Aug 27;5:14.PMID: 18727840 [PubMed - in process]Related articlesFree article

    2.

    14-3-3 protein, total tau and phosphorylated tau in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease and neurodegenerative disease in Japan.

    Satoh K, Shirabe S, Eguchi H, Tsujino A, Eguchi K, Satoh A, Tsujihata M, Niwa M, Katamine S, Kurihara S, Matsuo H.

    Cell Mol Neurobiol. 2006 Feb;26(1):45-52.PMID: 16633900 [PubMed - indexed for MEDLINE]Related articles

    3.

    Phospho-tau/total tau ratio in cerebrospinal fluid discriminates Creutzfeldt-Jakob disease from other dementias.

    Riemenschneider M, Wagenpfeil S, Vanderstichele H, Otto M, Wiltfang J, Kretzschmar H, Vanmechelen E, Förstl H, Kurz A.

    Mol Psychiatry. 2003 Mar;8(3):343-7.PMID: 12660807 [PubMed - indexed for MEDLINE]Related articles

    4.

    Follow-up investigations of tau protein and S-100B levels in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

    Cepek L, Steinacker P, Mollenhauer B, Wiese B, Ciesielczyk B, Bibl M, Wiltfang J, Zerr I, Schulz-Schaeffer W, Kretzschmar HA, Poser S, Otto M.

    Dement Geriatr Cogn Disord. 2005;19(5-6):376-82. Epub 2005 Mar 30.PMID: 15802913 [PubMed - indexed for MEDLINE]Related articles

    5.

    Diagnostic value of 14-3-3beta immunoblot and T-tau/P-tau ratio in clinically suspected Creutzfeldt-Jakob disease.

    Blennow K, Johansson A, Zetterberg H.

    Int J Mol Med. 2005 Dec;16(6):1147-9.PMID: 16273298 [PubMed - indexed for MEDLINE]Related articles

    6.

    [Proportion of tau protein to phosphorylated tau protein CSF levels in differential diagnosis of dementia]

    Hort J, Valis M, Waberzinek G, Taláb R, Glossová L, Bojar M, Vyhnálek M, Skoda D, Masopust J, Stourac P.

    Nervenarzt. 2008 Aug;79(8):891-2, 894-6, 898. German. PMID: 18626620 [PubMed - indexed for MEDLINE]Related articles

    7.

    Diagnostic value of CSF protein profile in a Portuguese population of sCJD patients.

    Baldeiras IE, Ribeiro MH, Pacheco P, Machado A, Santana I, Cunha L, Oliveira CR.

    J Neurol. 2009 Sep;256(9):1540-50. Epub 2009 May 6.PMID: 19418113 [PubMed - indexed for MEDLINE]Related articles

    8.

    Dissociation between CSF total tau and tau protein phosphorylated at threonine 231 in Creutzfeldt-Jakob disease.

    Buerger K, Otto M, Teipel SJ, Zinkowski R, Blennow K, DeBernardis J, Kerkman D, Schröder J, Schönknecht P, Cepek L, McCulloch C, Möller HJ, Wiltfang J, Kretzschmar H, Hampel H.

    Neurobiol Aging. 2006 Jan;27(1):10-5.PMID: 16298235 [PubMed - indexed for MEDLINE]Related articles

    9.

    Total tau protein in cerebrospinal fluid and diffusion-weighted MRI as an early diagnostic marker for Creutzfeldt-Jakob disease.

    Satoh K, Shirabe S, Tsujino A, Eguchi H, Motomura M, Honda H, Tomita I, Satoh A, Tsujihata M, Matsuo H, Nakagawa M, Eguchi K.

    Dement Geriatr Cogn Disord. 2007;24(3):207-12. Epub 2007 Aug 10.PMID: 17690553 [PubMed - indexed for MEDLINE]Related articles

    10.

    Cerebrospinal fluid {beta}-amyloid 42 and tau proteins as biomarkers of Alzheimer-type pathologic changes in the brain.

    Tapiola T, Alafuzoff I, Herukka SK, Parkkinen L, Hartikainen P, Soininen H, Pirttilä T.

    Arch Neurol. 2009 Mar;66(3):382-9.PMID: 19273758 [PubMed - indexed for MEDLINE]Related articlesFree article

    11.

    Elevated levels of tau-protein in cerebrospinal fluid of patients with Creutzfeldt-Jakob disease.

    Otto M, Wiltfang J, Tumani H, Zerr I, Lantsch M, Kornhuber J, Weber T, Kretzschmar HA, Poser S.

    Neurosci Lett. 1997 Apr 11;225(3):210-2.PMID: 9147407 [PubMed - indexed for MEDLINE]Related articles

    12.

    CSF biomarkers and incipient Alzheimer disease in patients with mild cognitive impairment.

    Mattsson N, Zetterberg H, Hansson O, Andreasen N, Parnetti L, Jonsson M, Herukka SK, van der Flier WM, Blankenstein MA, Ewers M, Rich K, Kaiser E, Verbeek M, Tsolaki M, Mulugeta E, Rosén E, Aarsland D, Visser PJ, Schröder J, Marcusson J, de Leon M, Hampel H, Scheltens P, Pirttilä T, Wallin A, Jönhagen ME, Minthon L, Winblad B, Blennow K.

    JAMA. 2009 Jul 22;302(4):385-93.PMID: 19622817 [PubMed - indexed for MEDLINE]Related articlesFree article

    13.

    The diagnostic efficiency of biomarkers in sporadic Creutzfeldt-Jakob disease compared to Alzheimer's disease.

    Bahl JM, Heegaard NH, Falkenhorst G, Laursen H, Høgenhaven H, Mølbak K, Jespersgaard C, Hougs L, Waldemar G, Johannsen P, Christiansen M.

    Neurobiol Aging. 2009 Nov;30(11):1834-41. Epub 2008 Mar 12.PMID: 18339451 [PubMed - indexed for MEDLINE]Related articles

    14.

    [CSF-analyses in clinical diagnosis of Creutzfeldt-Jakob disease. A literature review and three cases from routine clinical practice]

    Blennow K, Lind B, Andersson E, Andreasen N.

    Lakartidningen. 2001 May 16;98(20):2446-51. Swedish. PMID: 11433975 [PubMed - indexed for MEDLINE]Related articles

    15.

    Glial fibrillary acidic protein and protein S-100B: different concentration pattern of glial proteins in cerebrospinal fluid of patients with Alzheimer's disease and Creutzfeldt-Jakob disease.

    Jesse S, Steinacker P, Cepek L, von Arnim CA, Tumani H, Lehnert S, Kretzschmar HA, Baier M, Otto M.

    J Alzheimers Dis. 2009 Jul;17(3):541-51.PMID: 19433893 [PubMed - indexed for MEDLINE]Related articles

    16.

    Tau protein and 14-3-3 protein in the differential diagnosis of Creutzfeldt-Jakob disease.

    Otto M, Wiltfang J, Cepek L, Neumann M, Mollenhauer B, Steinacker P, Ciesielczyk B, Schulz-Schaeffer W, Kretzschmar HA, Poser S.

    Neurology. 2002 Jan 22;58(2):192-7.PMID: 11805244 [PubMed - indexed for MEDLINE]Related articles

    17.

    Cerebrospinal fluid markers in differential diagnosis of Alzheimer's disease and vascular dementia.

    Boban M, Grbić K, Mladinov M, Hof PR, Süssmair C, Ackl N, Stanić G, Bader B, Danek A, Simić G.

    Coll Antropol. 2008 Jan;32 Suppl 1:31-6.PMID: 18405055 [PubMed - indexed for MEDLINE]Related articles

    18.

    The brain injury biomarker VLP-1 is increased in the cerebrospinal fluid of Alzheimer disease patients.

    Lee JM, Blennow K, Andreasen N, Laterza O, Modur V, Olander J, Gao F, Ohlendorf M, Ladenson JH.

    Clin Chem. 2008 Oct;54(10):1617-23. Epub 2008 Aug 14.PMID: 18703769 [PubMed - indexed for MEDLINE]Related articlesFree article

    19.

    [Cerebrospinal fluid amyloid beta and tau protein: biomarkers for Alzheimer's disease]

    Mandić G, Marković I, Ostojić M, Stojković T, Misirlić-Dencić S, Zivanović-Radnić T, Stefanović R, Bumbasirević M, Stefanova E, Kostić V.

    Vojnosanit Pregl. 2008 Dec;65(12):901-5. Serbian. PMID: 19160984 [PubMed - indexed for MEDLINE]Related articles

    20.

    The Cerebrospinal Fluid Amyloid beta(42/40) Ratio in the Differentiation of Alzheimer's Disease from Non-Alzheimer's Dementia.

    Spies PE, Slats D, Sjögren JM, Kremer BP, Verhey FR, Rikkert MG, Verbeek MM.

    Curr Alzheimer Res. 2009 Dec 31. [Epub ahead of print]PMID: 20043812 [PubMed - as supplied by publisher]Related articles

    Display Settings:

    Format
    Items per page
    Sort by

    Send to:

    Choose Destination

    Supplemental Content

    Find related data

    Write to the Help Desk